Skip to main content

5 Result(s)

within **a Wang MD Remove this filter Cardiology Remove this filter Internal Medicine Remove this filter Metabolic Diseases Remove this filter

and

  1. No Access

    Article

    Ongoing trials: What should we expect after ALLHAT?

    The publication of the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) results, when used in conjunction with a new meta-analysis, provides hypertension research with a wat...

    Ji-Guang Wang MD, Jan A. Staessen MD, PhD… in Current Hypertension Reports (2003)

  2. No Access

    Article

    The benefit of treating isolated systolic hypertension

    Isolated systolic hypertension affects over 15% of all people older than 60 years of age. In the elderly, systolic hypertension is a major modifiable cardiovascular risk factor. Systolic blood pressure is asso...

    Ji-Guang Wang MD, Jan A. Staessen MD, PhD in Current Hypertension Reports (2001)

  3. No Access

    Article

    Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation

    In the past, virtually all of the physiologic actions of angiotensin II (ANG II) were thought to be mediated by the type-1 ANG II receptor. However, there is now a compelling body of evidence suggesting that t...

    Robert M. Carey MD, Zhi-Qin Wang MD, Helmy M. Siragy MD in Current Hypertension Reports (2000)

  4. No Access

    Article

    Clinical trials in isolated systolic hypertension

    Isolated systolic hypertension affects 8% to 15% of all people older than 60 years of age. In the elderly, systolic hypertension is the major modifiable cardiovascular risk factor. Three placebo-controlled out...

    Jerzy Gasowski MD, Ji G. Wang MD, Jan A. Staessen MD, PhD in Current Hypertension Reports (1999)

  5. No Access

    Article

    Novel actions of angiotensin II via its renal type-2 (AT2) receptor

    The vast majority of the biologic effects of angiotensin II have been considered to be mediated by the subtype-1 (AT1) receptor. The AT2 receptor is expressed to a low degree in most adult cells and tissues, and ...

    Robert M. Carey MD, Zhi-Qin Wang MD, Helmy M. Siragy MD in Current Hypertension Reports (1999)